Changpu Yu
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Bone health and treatments
Papers in
-
- Protein Degradation and Inhibitors 3
- Bone Metabolism and Diseases 3
- Glycosylation and Glycoproteins Research 2
- Oncology 11
- CAR-T cell therapy research 6
- Co-authors
- John Latham (4 shared papers)James C. Geoghegan (4 shared papers)David G. Winkler (4 shared papers)May Kung Sutherland (6 shared papers)John E. Skonier (3 shared papers)May S.K. Sutherland (8 shared papers)George C. Yeoh (2 shared papers)Nelson Fausto (2 shared papers)
- Journals
- Blood (10 papers)Journal of Biological Chemistry (3 papers)Bone (2 papers)mAbs (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Changpu Yu
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 87
- Hepatology 192
- Oncology 611
- Orthopedics and Sports Medicine 127
- Hematology 162
- Radiology, Nuclear Medicine and Imaging 263
Countries citing papers authored by Changpu Yu
This map shows the geographic impact of Changpu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changpu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changpu Yu more than expected).
Fields of papers citing papers by Changpu Yu
This network shows the impact of papers produced by Changpu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changpu Yu. The network helps show where Changpu Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changpu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 293 | |
| 2 | 2000 | 242 | |
| 3 | 2006 | 224 | |
| 4 | 2004 | 180 | |
| 5 | 2003 | 158 | |
| 6 | 2004 | 139 | |
| 7 | 2004 | 82 | |
| 8 | 2004 | 69 | |
| 9 | 2009 | 32 | |
| 10 | 2010 | 24 | |
| 11 | 2015 | 18 | |
| 12 | 2017 | 18 | |
| 13 | 2012 | 8 | |
| 14 | 2015 | 8 | |
| 15 | 2018 | 7 | |
| 16 | 2015 | 4 | |
| 17 | 2014 | 2 | |
| 18 | 2006 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2021 | 2 |
About Changpu Yu
Changpu Yu is a scholar working on Molecular Biology, Oncology, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 22 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (8 papers), CAR-T cell therapy research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (3 papers), Bone Metabolism and Diseases (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Hepatology (192 citations), Oncology (611 citations), Orthopedics and Sports Medicine (127 citations), Hematology (162 citations) and Radiology, Nuclear Medicine and Imaging (263 citations). Changpu Yu has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include John Latham, James C. Geoghegan, David G. Winkler, May Kung Sutherland, John E. Skonier, May S.K. Sutherland, George C. Yeoh, Nelson Fausto, Jonathan A. Rhim and Eileen Turcott. Their work appears in journals such as Blood, Journal of Biological Chemistry, Bone, mAbs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.